Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
Details for Australian Patent Application No. 2004222090 (hide)
International Classifications
Event Publications
13 October 2005 PCT application entered the National Phase
PCT publication WO2004/083208 Priority application(s): WO2004/083208
26 July 2007 Application Accepted
Published as AU-B-2004222090
29 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004222095-Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
2004222089-Humanized anti-CD4 antibody with immunosuppressive properties
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser